Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no active enrollment. New help sections are added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment header is updated alongside a revision tag advancing to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T14:08:29.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.5.5 has been added to the page. The previous revision tag Revision: v3.5.4 has been removed.
    Difference
    0.1%
    Check dated 2026-06-05T09:27:17.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, signaling a new page version was published; such updates typically reflect editorial or backend adjustments rather than changes to essential content.
    Difference
    0.1%
    Check dated 2026-05-15T04:57:20.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, replacing Revision: v3.5.2, indicating a minor backend/content update without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:23:56.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2; no visible changes to page content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-04-16T11:00:44.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:03.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.